The safety and tolerability of aripiprazole once-monthly as maintenance treatment for bipolar I disorder: A double-blind, placebo-controlled, randomized withdrawal study.

Joseph R Calabrese,Raymond Sanchez,Na Jin,Joan Amatniek,Kevin Cox,Brian Johnson,Pamela P Perry,Peter Hertel,Pedro Such,Robert D McQuade,Margaretta Nyilas,William H Carson

Journal of Affective Disorders（2018）

引用 13|浏览32

暂无评分

摘要

•AOM 400 is the first and only once-monthly LAI antipsychotic for BP-I.•AOM 400 safety and tolerability are assessed and characterized.•Treatment emergent AEs include time-limited akathisia and weight gain.•A favorable safety profile supports AOM 400 use for maintenance treatment of BP-I.

查看译文

关键词

Aripiprazole once-monthly,Long-acting injectable antipsychotic,Maintenance therapy,Bipolar I disorder

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要